Reactivity of the cardiovascular system in the tetraplegic patient.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004562:Electrocardiography; D006145:Guanethidine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007741:Labetalol / Q000494:pharmacology; D008297:Male; D005996:Nitroglycerin / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011187:Posture; D011433:Propranolol / Q000494:pharmacology; D011782:Quadriplegia / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D013599:Systole / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D010643:Phenoxybenzamine; D001285:Atropine; D011433:Propranolol; D005996:Nitroglycerin; D007741:Labetalol; D006145:Guanethidine